Electrochemotherapy treatment of locally advanced and metastatic soft tissue sarcomas: Results of a non-comparative phase II study

World Journal of Surgery

Volumn 38, Issue 4, 2014, Pages 813-822

  Campana, Luca G ^a   Bianchi, Giuseppe ^b   Mocellin, Simone ^c   Valpione, Sara ^c   Campanacci, Laura ^b   Brunello, Antonella ^a   Donati, Davide ^b   Sieni, Elisabetta ^c   Rossi, Carlo R ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; BLEOMYCIN;

ADULT; AGED; ARTICLE; DRUG ADMINISTRATION; ELECTROCHEMOTHERAPY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PALLIATIVE THERAPY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; SARCOMA; SKIN TUMOR; SOFT TISSUE TUMOR; SURVIVAL; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; DRUG ADMINISTRATION SCHEDULE; ELECTROCHEMOTHERAPY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PALLIATIVE CARE; SARCOMA; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84897116984     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-2321-1     Document Type: Article

References (33)

1. Karavasilis V, Seddon BM, Ashley S, Al-Muderis O, Fisher C, Judson I (2008) Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients. Cancer 112:1585-1591
2. Mir LM, Morsli N, Garbay JR, Billard V, Robert C, Marty M (2003) Electrochemotherapy: a new treatment of solid tumors. J Exp Clin Cancer Res 22:145-148
3. Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr, Mir LM (1993) Electrochemotherapy, a new antitumour treatment. First clinical phase I-II trial. Cancer 72:3694-3700
4. Gehl J, Geertsen PF (2000) Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 10:585-589
5. Byrne CM, Thompson JF, Johnston H, Hersey P, Quinn MJ, Michael Hughes T et al (2005) Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy). Melanoma Res 15:45-51
6. Heller R, Gilbert R, Jaroszeski MJ (1999) Clinical applications of electrochemotherapy. Adv Drug Deliv Rev 35:119-129
7. Mir LM, Devauchelle P, Quintin-Colonna F et al (1997) First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br J Cancer 76:1617-1622
8. Hyacinthe M, Jaroszeski MJ, Dang VV et al (1999) Electrically enhanced drug delivery for the treatment of soft tissue sarcoma. Cancer 85:409-417
9. Horiuchi A, Nikaido T, Mitsushita J et al (2000) Enhancement of antitumour effect of bleomycin by low-voltage in vivo electroporation: a study of human uterine leiomyosarcomas in nude mice. Int J Cancer 88:640-644
10. Sersa G, Jarm T, Kotnik T et al (2008) Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 98:388-398
11. Shimizu T, Nikaido T, Gomyo H et al (2003) Electrochemotherapy for digital chondrosarcoma. J Orthop Sci 8:248-251
12. de Bree R, Tijink BM, van Groeningen CJ, Leemans CR (2006) Electroporation therapy in soft tissue sarcoma: a potentially effective novel treatment. Sarcoma 85234. doi: 10.1155/SRCM/2006/85234
13. Curatolo P, Quaglino P, Marenco F et al (2012) Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial. Ann Surg Oncol 19:192-198
14. Latini A, Bonadies A, Trento E et al (2012) Effective treatment of Kaposi's sarcoma by electrochemotherapy and intravenous bleomycin administration. Dermatol Ther 25:214-218
15. Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, Geertsen PF, Rudolf Z, O'Sullivan GC, Marty M (2006) Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator by means of invasive or non-invasive electrodes. EJC Suppl 4:14-25
16. The EuroQoL Group (1990) EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 16:199-208
17. Corovic S, Al Sakere B, Haddad V, Miklavcic D, Mir LM (2008) Importance of contact surface between electrodes and treated tissue in electrochemotherapy. Technol Cancer Res Treat 7:393-400
18. Marty M, Sersa G, Garbay J et al (2006) Electrochemotherapy - an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl 4:3-13
19. Bryant J, Day R (1995) Incorporating toxicity considerations into the design of two-stage phase II clinical trials. Biometrics 51:1372-1383
20. Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G (1998) The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 74(5):2152-2158
21. Kos B, Zupanic A, Kotnik T, Snoj M, Sersa G, Miklavcic D (2010) Robustness of treatment planning for electrochemotherapy of deep-seated tumours. J Membr Biol 236:147-153
22. Miklavčič D, Pavšelj N, Hart FX 2006) Electric properties of tissues. Wiley Encyclopedia of Biomedical Engineering. Wiley. doi: 10.1002/9780471740360.ebs0403
23. Deneve JL, Zager JS (2012) Isolated regional therapy for advanced extremity soft tissue sarcomas. Surg Oncol Clin N Am 21:287-299
24. Campana LG, Mocellin S, Basso M, Puccetti O, De Salvo GL, Chiarion-Sileni V et al (2009) Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol 16:191-199
25. Campana LG, Valpione S, Falci C et al (2012) The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study. Breast Cancer Res Treat 134:1169-1178
26. Mali B, Miklavcic D, Cemazar M et al (2013) Tumour size and effectiveness of electrochemotherapy. Radiol Oncol 47:32-41
27. Judson I, Verweij J, Gelderblom H et al (2012) Results of a randomised phase III trial (EORTC 62012) of single agent doxorubicin versus doxorubicin plus ifosfamide as first line chemotherapy for patients with advanced or metastatic soft tissue sarcoma: a survival study by the EORTC soft tissue and bone sarcoma group. Abstract LBA7. Ann Oncol. doi: 10.1093/annonc/mds499
28. Gehl J, Skovsgaard T, Mir LM (1998) Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs 9:319-325
29. Penel N, Van Glabbeke M, Marreaud S, Ouali M, Blay JY, Hohenberger P (2011) Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years. Ann Oncol 22:1266-1272
30. Tepper JE, Suit HD (1985) Radiation therapy alone for sarcoma of soft tissue. Cancer 56:475-479
31. Jarm T, Cemazar M, Miklavcic D, Sersa G (2010) Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 10:729-746
32. Sleijfer S, Gorlia T, Lamers C et al (2012) Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study. Br J Cancer 107:639-645
33. Rossi CR, Vecchiato A, Mastrangelo G, Montesco MC, Russano F, Mocellin S et al (2013) Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET). Ann Oncol 24:1685-1691